Literature DB >> 2183172

Revised criteria for the classification of rheumatoid arthritis.

F C Arnett.   

Abstract

The Bulletin on the Rheumatic Diseases has published all of the classification criteria for the rheumatic diseases to date. These new revised classification criteria for rheumatoid arthritis are very important as they should provide understanding of the possibly changing face of rheumatoid arthritis.

Entities:  

Mesh：

Year:  1990        PMID： 2183172     DOI： 10.1097/00006416-199003000-00011

Source DB:  PubMed          Journal:  Orthop Nurs        ISSN： 0744-6020            Impact factor:   0.913


  4 in total

1.  Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.

Authors:  Alexander Espinosa; Janosch Hennig; Aurélie Ambrosi; Madhanagopal Anandapadmanaban; Martina Sandberg Abelius; Yi Sheng; Filippa Nyberg; Cheryl H Arrowsmith; Maria Sunnerhagen; Marie Wahren-Herlenius
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

2.  "You Obviously Just Have to Put on a Brave Face": A Qualitative Study of the Experiences and Coping Styles of Men With Rheumatoid Arthritis.

Authors:  Caroline A Flurey; Sarah Hewlett; Karen Rodham; Alan White; Robert Noddings; John R Kirwan
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

3.  'Everyone assumes a man to be quite strong': Men, masculinity and rheumatoid arthritis: A case-study approach.

Authors:  Caroline Flurey; Alan White; Karen Rodham; John Kirwan; Robert Noddings; Sarah Hewlett
Journal:  Sociol Health Illn       Date:  2017-10-15

4.  Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.

Authors:  Joshua F Baker; Bryant R England; Michael George; Grant Cannon; Brian Sauer; Alexis Ogdie; Bartlett C Hamilton; Carlos Hunter; Michael J Duryee; Geoffrey Thiele; Ted R Mikuls
Journal:  Ann Rheum Dis       Date:  2021-01-04       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.